Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a ...

The government revised Schedule M under the Drugs & Cosmetic Act in 2023 to make it mandatory for companies to follow Good ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

As the Estée Lauder Cos. is looking to bulk up its innovation capabilities, it’s looking to another industry for its latest ...

The pharmaceutical industry has long relied on data-driven decision-making to advance drug discovery, improve clinical trials ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...